Other Benefits Weight Loss Drugs May Be Able to Offer
TAIWAN, JUL 15 – A seven-year study of 60,000 people found GLP agonist drugs reduced dementia risk by 37% and stroke risk by 19% in individuals with type 2 diabetes and obesity.
- Researchers examined health records of 60,000 individuals living with obesity and type 2 diabetes from 2017 to 2024, identifying associations with decreased risks of dementia and stroke.
- They conducted a seven-year study comparing users of GLP-1 receptor agonists, such as semaglutide and tirzepatide, with patients taking different types of antidiabetic medications.
- The study revealed that individuals using these medications experienced a 37% decrease in the likelihood of developing dementia, a 19% drop in stroke risk, and were 30% less likely to die prematurely.
- Researchers indicated that the results point to possible protective effects on brain health and blood vessels that extend past glucose regulation, but emphasized the necessity of randomized controlled trials to establish a causal relationship.
- The findings suggest these medications could help lower the risk of dementia and stroke among adults managing type 2 diabetes alongside obesity, although additional research is needed to confirm their long-term benefits.
25 Articles
25 Articles
Other benefits weight loss drugs may be able to offer
For Tuesday, July 15, WGN’s Dina Bair has the latest on new medical information, including: Other benefits of weight loss drugs GLP-1 agonists may boost brain power and precent deadly neurological conditions. The Journal of the American Medical Association reports using medications like semaglutide and tirzepatide, sold as Wegovy, Ozempic, Mounjaro and Zepbound, is associated with a lower risk for dementia, stroke and mortality in adults with ty…
Weight loss jabs 'may protect against dementia and stroke ...


Hidden health benefits from weight-loss shots revealed
The study saw experts from Taiwan examine data on 60,000 people from around the world


Weight-loss jabs linked to 37 per cent lower risk of dementia
Those on the jabs were also found to have a 19% lower risk of having a stroke
Coverage Details
Bias Distribution
- 59% of the sources are Center
To view factuality data please Upgrade to Premium